Prototype strategies for diagnosing and treating brain disorders

New technologies for mapping biological specimens, recording brain activity and signaling, controlling brain activity and signaling, and building brain circuits, may be capable someday of serving in diagnostic or therapeutic roles, helping improve the health of human patients. We are applying our technologies for molecular mapping, dynamical control, and dynamical recording to clinically relevant problems. We are applying our molecular mapping tools to human clinical specimens such as biopsies from cancer patients, organoids and in vitro cultures derived from human cells, and specimens of human pathogens. We are inventing new noninvasive methods for targetedly controlling brain dynamics, such as methods that utilize the nonlinearity of neurons to focus on specific regions deep in the brain. We are assessing, often in collaborations with other groups, the translational possibilities opened up by our technologies, exploring the safety and efficacy of our technologies in preclinical animal models. Sometime this requires adaptation of technologies in new forms, that maximize efficacy and safety, or minimize invasiveness. For example, optogenetic tools may be need to be made that respond to red light and thus are less invasive, brain stimulation devices may need to be made into wireless and less invasive forms, optical neural recording may benefit from new geometries and materials that increase the resolving power of optical fibers, brain surgery may benefit from robotic automation, and genetic circuits may benefit from encapsulation in synthetic minimal cells that facilitate their safe and effective operation. We are also working with groups who are utilizing our molecular mapping, dynamical control, and dynamical recording tools to design new kinds of intervention, based upon newly revealed neuroscience, that may help human patients, e.g. noninvasive methods that may help patients with Alzheimer’s disease and other diseases. New kinds of "brain co-processor" may be possible which can work efficaciously with the brain to augment its computational abilities, e.g. in the context of cognitive, emotional, sensory, or motor disability.

Publications

Gamma frequency sensory stimulation in mild probable Alzheimer’s dementia patients: Results of feasibility and pilot studies

PLoS One | 2022

Chan D, Suk HJ, Jackson BL, Milman NP, Stark D, Klerman EB, Kitchener E, Fernandez Avalos VS, de Weck G, Banerjee A, Beach SD, Blanchard J, Stearns C, Boes AD, Uitermarkt B, Gander P, Howard M 3rd, Sternberg EJ, Nieto-Castanon A, Anteraper S, Whitfield-Gabrieli S, Brown EN, Boyden ES, Dickerson BC, Tsai LH (2022) Gamma frequency sensory stimulation in mild probable Alzheimer's dementia patients: Results of feasibility and pilot studies, PLoS One 17(12):e0278412.

Proceedings of the Sixth Deep Brain Stimulation Think Tank Modulation of Brain Networks and Application of Advanced Neuroimaging, Neurophysiology, and Optogenetics

Frontiers in Neuroscience | 2019

Ramirez-Zamora A, Giordano J, Boyden ES, Gradinaru V, Gunduz A, Starr PA, Sheth SA, McIntyre CC, Fox MD, Vitek J, Vedam-Mai V, Akbar U, Almeida L, Bronte-Stewart HM, Mayberg HS, Pouratian N, Gittis AH, Singer AC, Creed MC, Lazaro-Munoz G, Richardson M, Rossi MA, Cendejas-Zaragoza L, D'Haese PF, Chiong W, Gilron R, Chizeck H, Ko A, Baker KB, Wagenaar J, Harel N, Deeb W, Foote KD, Okun MS (2019) Proceedings of the Sixth Deep Brain Stimulation Think Tank Modulation of Brain Networks and Application of Advanced Neuroimaging, Neurophysiology, and Optogenetics, Frontiers in Neuroscience 13:936.

Maps of Mechanisms

Cell | 2018

Boyden, E. S. (2018) Maps of Mechanisms, “Building a Better Brain” Voices Feature, Cell 175(3):633-634.

Nanoscale imaging of clinical specimens using pathology-optimized expansion microscopy

Nature Biotechnology | 2017

Zhao Y*, Bucur O*, Irshad H, Chen F, Weins A, Stancu AL, Oh EY, DiStasio M, Torous V, Glass B, Stillman IE, Schnitt SJ, Beck AH**, Boyden ES** (2017) Nanoscale imaging of clinical specimens using pathology-optimized expansion microscopy, Nature Biotechnology 35(8):757-764. (*, co-first authors; **, co-corresponding authors)

The promise of organ and tissue preservation to transform medicine

Nature Biotechnology | 2017

Giwa S, Lewis JK, Alvarez L, Langer R, Roth AE, Church GM, Markmann JF, Sachs DH, Chandraker A, Wertheim JA, Rothblatt M, Boyden ES, Eidbo E, Lee WPA, Pomahac B, Brandacher G, Weinstock DM, Elliott G, Nelson D, Acker JP, Uygun K, Schmalz B, Weegman BP, Tocchio A, Fahy GM, Storey KB, Rubinsky B, Bischof J, Elliott JAW, Woodruff TK, Morris GJ, Demirci U, Brockbank KGM, Woods EJ, Ben RN, Baust JG, Gao D, Fuller B, Rabin Y, Kravitz DC, Taylor MJ, Toner M (2017) The promise of organ and tissue preservation to transform medicine, Nature Biotechnology 35(6):530-542.

Expansion mini-microscopy: An enabling alternative in point-of-care diagnostics

Current Opinion in Biomedical Engineering | 2017

Yu Shrike Zhang, Grissel Trujillo-de Santiago, Mario Moisés Alvarez, Steven J. Schiff, Edward S. Boyden*, Ali Khademhosseini* (2017) Expansion Mini-Microscopy: An Enabling Alternative in Point-of-Care Diagnostics, Current Opinion in Biomedical Engineering 1:45-53. (*, co-corresponding authors)

Gamma frequency entrainment attenuates amyloid load and modifies microglia

Nature | 2016

Iaccarino HF*, Singer AC*, Martorell AJ, Rudenko A, Gao F, Gillingham TZ, Mathys H, Seo J, Kritskiy O, Abdurrob F, Adaikkan C, Canter RG, Rueda R, Brown EN, Boyden ES, Tsai LH (2016) Gamma frequency entrainment attenuates amyloid load and modifies microglia, Nature 540(7632):230-235. (*, co-first authors)

Hybrid Microscopy: Enabling Inexpensive High-Performance Imaging through Combined Physical and Optical Magnifications

Scientific Reports | 2016

Zhang YS*, Chang JB*, Alvarez MM, Trujillo-de Santiago G, Aleman J, Batzaya B, Krishnadoss V, Ramanujam AA, Kazemzadeh-Narbat M, Chen F, Tillberg PW, Dokmeci MR, Boyden ES**, Khademhosseini A.** (2016) Hybrid Microscopy: Enabling Inexpensive High-Performance Imaging through Combined Physical and Optical Magnifications, Scientific Reports 6:22691. (* co-first authors, ** co-corresponding authors)

Closed-loop, ultraprecise, automated craniotomies

Journal of Neurophysiology | 2015

Pak N, Siegle JH*, Kinney JP*, Denman DJ, Blanche TJ, Boyden ES (2015) Closed-loop, ultraprecise, automated craniotomies, Journal of Neurophysiology 113(10):3943-53. (*, equal contribution)

Optogenetics and Translational Medicine

Science Translational Medicine | 2013

Chow, B. Y.* and Boyden, E. S.* (2013) Optogenetics and Translational Medicine, Science Translational Medicine 5(177):177ps5. (* co-corresponding authors)

The best of times, the worst of times for psychiatric disease

Nature Neuroscience | 2012

Karayiorgou M., Flint J., Gogos J.A., Malenka R.C.; the Genetic and Neural Complexity in Psychiatry 2011 Working Group (Bargmann C.I., Boyden E.S., Bullmore E.T., Chan A.W., Davis M., Deisseroth K., Dolmetch R.E., Eggan K., Fears S.C., Freimer N.B., Geschwind D.H., Gordon J., Nickerson D.A., Vanderhaeghen P., Axel R., Zuker C.S., Fischbach G.) (2012) The best of times, the worst of times for psychiatric disease, Nature Neuroscience 15(6):811-812.

Virally delivered Channelrhodopsin-2 Safely and Effectively Restores Visual Function in Multiple Mouse Models of Blindness

Molecular Therapy | 2011

Doroudchi, M. M., Greenberg, K. P., Liu, J., Silka, K. A., Boyden, E. S., Lockridge, J. A., Arman, A. C., Janani, R., Boye, S. E., Boye, S. L., Gordon, G. M., Matteo, B. C., Sampath, A. P., Hauswirth, W. W., Horsager, A. (2011) Virally delivered Channelrhodopsin-2 Safely and Effectively Restores Visual Function in Multiple Mouse Models of Blindness, Molecular Therapy 19(7):1220-9.

Brain Coprocessors

Technology Review | 2010

Boyden, E. S., Allen, B. D., Fritz, D. (2010) "Brain Coprocessors." Column, Technology Review. 9/23/2010.